US Patent 7510857 Thermostable cellulase and methods of use
Patent 7510857 was granted and assigned to C5-6 TECHNOLOGIES on March, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+329 characters)
Article
Patent abstract
A Clostridium thermocellum thermostable cellulase enzyme with both endocellulase activity and exocellulase activity that is able to degrade cellulose in the absence of scaffolding and other cellulosomic proteins is provided. The use of the enzyme to degrade cellulosic materials to soluble sugars is also provided.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07510857 Thermostable cellulase and methods of use US Patent 7510857 Thermostable cellulase and methods of use
Infobox
Patent Number
0751085700
Patent Number
751085700
Edits on 23 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075108570
Date of Patent
March 31, 2009
0Patent Application Number
117412540
Date Filed
April 27, 2007
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075108570
Date of Patent
March 31, 2009
0Patent Application Number
117412540
Date Filed
April 27, 2007
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07510857 Thermostable cellulase and methods of use
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07510857
Date of patent
March 31, 2009
Patent application number
11741254
Date Filed
April 27, 2007
Patent primary examiner
Find more entities like US Patent 7510857 Thermostable cellulase and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
